Skip to main content

Advertisement

Log in

Psychopharmacology in supportive care of cancer: a review for the clinician

II. Neuroleptics

  • REVIEW ARTICLE
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

 Neuroleptics are frequently used in patients with advanced cancer. Most relevant and practical aspects of their use in supportive cancer care are reviewed, to assist the clinical oncologist and palliative care specialist when prescribing these drugs. This article reviews pharmacological properties, indications, such as delirium, nausea and vomiting, pain, anxiety and other symptoms, adverse effects, and drug interactions of neuroleptics and compares the profiles of different compounds. Special emphasis is put on the role of neuroleptics in the management of delirium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Published online: 10 December 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mazzocato, C., Stiefel, F., Buclin, T. et al. Psychopharmacology in supportive care of cancer: a review for the clinician . Support Care Cancer 8, 89–97 (2000). https://doi.org/10.1007/s005200050021

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005200050021

Navigation